Bone Support

Share Price

  • Contact Us
Follow
  • US site
    • Global English Site
    • Global Swedish Site
    • US site
  • Bonesupport
    • Message from the CEO
    • Vision & Mission
    • Sustainability
    • History
    • Management
    • The Board
    • Our Partners
    • Careers
  • Products
    • CERAMENT® BONE VOID FILLER
    • CERAMENT® G with Gentamicin
    • CERAMENT® BEAD TRAY
    • CERAMENT® Delivery Cannulas
    • Purchasing products
  • Innovation
    • Pipeline
    • CERTiFy Clinical Trial
  • Medical Professionals
    • TRAUMA: WHY USE CERAMENT®
    • BENIGN BONE TUMORS: WHY USE CERAMENT®
    • REVISION ARTHROPLASTY: WHY USE CERAMENT
    • FOOT AND ANKLE: WHY USE CERAMENT
  • Investors
    • Financials
    • Financial Reports
    • Presentations
    • The Share
    • Shareholders
    • Analyst Coverage
    • Corporate Governance
    • Calendar
    • Q&A
    • Definitions
  • Patients
    • Bone Grafts
    • BONE DEFECTS CAUSED BY TRAUMA
    • BONE DEFECTS CAUSED BY BENIGN BONE TUMORS
    • BONE DEFECTS CAUSED BY HIP AND KNEE REVISIONS
  • Media
    • Press Releases
    • Publications and Resources
    • Multimedia
    • Events
  • Contact Us
  • Global English Site
  • Global Swedish Site
  • US site
  • Financials
  • Financial Reports
  • Presentations
  • The Share
  • Shareholders
  • Analyst Coverage
  • Corporate Governance
  • Calendar
  • Q&A
  • Definitions

Financial Reports 2020

BONESUPPORT HOLDING AB was listed on Nasdaq Stockholm on 21st June 2017 and interim reports are published from Q2 2017.

PDF Icon

Annual Report 2020

13/04/2021

PDF Icon

Full Year Report 2020

17/02/2021

Net sales increased by 15 percent and amounted to SEK 53.2 million (46.2). The gross margin improved to 89.8 percent (88.9). Operating result amounted to SEK -26.7 million (-38.6).
PDF Icon

Interim Report, Q3, July - September 2020

05/11/2020

Net sales increased by 23 percent and amounted to SEK 48.1 million (39.1). The gross margin improved to 91.4 percent (87.7). Operating result amounted to SEK -19.2 million (-32.7).
PDF Icon

Interim Report, Q2, April – June 2020

17/07/2020

Net sales amounted to SEK 36.2 million (37.3), a decrease of 3%. Gross margin amounted to 86.7% (86.5). Operating result amounted to SEK -23.5 million (-47.8).
PDF Icon

Interim Report, Q1, January – March 2020

08/05/2020

Net sales amounted to SEK 43.4 million (32.8), an increase of 32%. Gross margin amounted to 88.7% (85.9). Operating profit totaled SEK -29.2 million (-39.0).

©BONESUPPORT AB 2022. ALL RIGHTS RESERVED. CERAMENT and BONESUPPORT are registered Trademarks of BONESUPPORT AB.

  • Home
  • Contact Us
  • Privacy Policy
  • Cookie Policy